Abstract | OBJECTIVES: We assessed whether administering cannabidiol (CBD) before recalling the traumatic event that triggered their disorder attenuates anxiety in patients with post-traumatic stress disorder ( PTSD). As an exploratory pilot analysis, we also investigated whether this effect depends on the nature of the event (sexual vs. nonsexual trauma). METHODS: Thirty-three patients of both sexes with PTSD were recruited and randomized 1:1 into two groups. One group received oral CBD (300 mg), and the other received a placebo before listening to a digital audio playback of their previously recorded report of the trigger event. Subjective and physiological measurements were taken before and after recall. We analyzed the data in two subsamples: trigger events involving sexual and nonsexual trauma. RESULTS: In the nonsexual trauma group, the differences between measurements before and after recall were significantly smaller with CBD than placebo; this held true for anxiety and cognitive impairment. However, in the sexual trauma group, the differences were non-significant for both measurements. CONCLUSION: A single dose of CBD (300mg) attenuated the increased anxiety and cognitive impairment induced by recalling a traumatic event in patients with PTSD when the event involved nonsexual trauma.
|
Authors | Lívia Maria Bolsoni, José Alexandre S Crippa, Jaime Eduardo Cecílio Hallak, Francisco Silveira Guimarães, Antonio Waldo Zuardi |
Journal | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)
(Braz J Psychiatry)
2022 May-Jun
Vol. 44
Issue 3
Pg. 298-307
ISSN: 1809-452X [Electronic] Brazil |
PMID | 35293520
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Anti-Anxiety Agents
- Cannabidiol
|
Topics |
- Anti-Anxiety Agents
(therapeutic use)
- Anxiety
(drug therapy)
- Anxiety Disorders
(drug therapy)
- Cannabidiol
(therapeutic use)
- Female
- Humans
- Male
- Stress Disorders, Post-Traumatic
(drug therapy, psychology)
|